Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
Medical Xpress
https://medicalxpress.com/news/2023-11-anti-clotting-medication-people-atrial-fibrillation.html